Insider · CIK 0001967946
Tage Honore
Files at VNDA (Vanda Pharmaceuticals Inc.). First filing Feb 24, 2026, latest Feb 24, 2026.
In brief
Tage Honore files SEC Form 4 as director at VNDA (Vanda Pharmaceuticals Inc.). Since Feb 24, 2026, Tage Honore has reported 0 open-market buys worth $0 and 1 open-market sell worth $241k, the latest filed on Feb 24, 2026.
A track record needs three past buys with six months of prices behind them; Tage Honore has 0, so none is measured yet.
The newest scored trade: sold $241k of VNDA on Feb 23, 2026, filed Feb 24, 2026, scored 48 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $241k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VNDA: Vanda Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Vanda Pharmaceuticals Inc. | $241k 30,000 shares | -24% | +108% from low-8% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 23, 2026 | VNDA Vanda Pharmaceuticals Inc. | 30,000 0.05% of outstanding | $241k | Feb 23, 2026 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | VNDA Vanda Pharmaceuticals Inc. | AGrant or award Common Stock | +41,600 | $0.00 | $0 | 135,069 | Jun 8, 2026 |
| Feb 23, 2026 | VNDA Vanda Pharmaceuticals Inc. | SOpen-market sale Common Stock | -30,000 | $8.03 | $241k | 93,469 | Feb 24, 2026 |
| Jun 5, 2025 | VNDA Vanda Pharmaceuticals Inc. | AGrant or award Common Stock | +59,225 | $0.00 | $0 | 123,469 | Jun 9, 2025 |
Questions about Tage Honore
Answered from the filings on this page, as of the latest one.
Is Tage Honore buying or selling?
In the last 12 months Tage Honore reported 0 open-market buys worth $0 and 1 open-market sell worth $241k on SEC Form 4; the latest was sold $241k of VNDA on Feb 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Tage Honore's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tage Honore has 0.
Where does Tage Honore file Form 4?
Tage Honore has filed Form 4 at VNDA (Vanda Pharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.